BACKGROUND: Measles-mumps-rubella (MMR) vaccine replaced monovalent measles vaccine in the routine childhood vaccination schedule in Israel in December 1988, primarily to achieve the elimination of the congenital rubella syndrome. In this observational study, we report on changes in reported mumps incidence in Israel from the time of the introduction of MMR vaccine until the end of 1998. METHODS: The report is based upon passive national surveillance of mumps incidence, which has been notifiable in Israel since 1977. RESULTS: Reported mumps incidence in Israel is now less than 2% the pre-vaccine incidence. CONCLUSIONS: In the decade since the introduction of routine mumps vaccination in 1-year-olds in Israel, mumps control has been achieved. Although small outbreaks occur and may continue to occur in future years, because of under-vaccination of children, primary vaccine failure and waning immunity, it can tentatively be said that mumps is no longer a public health problem in Israel.
BACKGROUND:Measles-mumps-rubella (MMR) vaccine replaced monovalent measles vaccine in the routine childhood vaccination schedule in Israel in December 1988, primarily to achieve the elimination of the congenital rubella syndrome. In this observational study, we report on changes in reported mumps incidence in Israel from the time of the introduction of MMR vaccine until the end of 1998. METHODS: The report is based upon passive national surveillance of mumps incidence, which has been notifiable in Israel since 1977. RESULTS: Reported mumps incidence in Israel is now less than 2% the pre-vaccine incidence. CONCLUSIONS: In the decade since the introduction of routine mumps vaccination in 1-year-olds in Israel, mumps control has been achieved. Although small outbreaks occur and may continue to occur in future years, because of under-vaccination of children, primary vaccine failure and waning immunity, it can tentatively be said that mumps is no longer a public health problem in Israel.
Authors: P A Briss; L J Fehrs; R A Parker; P F Wright; E C Sannella; R H Hutcheson; W Schaffner Journal: J Infect Dis Date: 1994-01 Impact factor: 5.226
Authors: Steven A Rubin; Malen A Link; Christian J Sauder; Cheryl Zhang; Laurie Ngo; Bert K Rima; W Paul Duprex Journal: J Virol Date: 2011-11-09 Impact factor: 5.103